Hollandbio welcomes J&S Preclinical Solutions

Hollandbio connects, represents and supports the Dutch biotech sector. We are very proud to represent more than 270 companies: from start-ups, small and medium-sized enterprises to large companies, active in health, nutrition or biobased economy. Today we welcome our newest member, J&S Preclinical Solutions, which specializes in supporting small to mid-sized companies with their non-clinical package from proof-of-concept studies to GLP toxicology studies, preparation of the nonclinical sections of the regulatory dossiers and the interaction with the regulatory authorities.

With a strong integrated approach to preclinical pharmacology and toxicology, J&S Preclinical Solutions aims to elevate drug development programs efficiently and effectively. They specialize in developing preclinical strategies and in executing pharmacology and toxicology studies. They believe that early integration of toxicology and pharmacology readouts strengthens and accelerates the drug development process.

Clients commend their decades of experience in preclinical safety assessment and in vivo efficacy in immunology and oncology and highlight their proactive approach, outside the box thinking, taking responsibility, and dedication to excellence.

The J&S Preclinical Solutions team is led by Sjeng Horbach, a Toxicology expert with over 40 years of experience, and Julien Villaudy, an experienced pharmacologist with over 15 years of expertise in academia and industry. As part of their commitment to fostering a collaboration, the company is offering a complimentary first consultation to hollandbio members. Feel free to reach out to the team for a discussion. They look forward to connecting and contributing to your preclinical program!